Why CGM transforms diabetes management
Traditional blood glucose monitoring — finger sticks several times per day — provides snapshots. CGM provides a continuous stream of data, updated every 1–5 minutes, 24 hours a day. This difference is transformative for diabetes management.
Trend arrows show not just where your glucose is but where it's going and how fast. A reading of 120 mg/dL with a rapidly falling arrow requires a different response than 120 mg/dL with a stable arrow. This context is impossible to get from a finger stick.
Overnight monitoring catches dangerous lows during sleep — when symptoms aren't detectable and intervention is impossible without CGM alerts. Nocturnal hypoglycemia is one of the most serious risks in intensive diabetes management.
Behavioral feedback makes the glucose impact of food, exercise, stress, and sleep immediately visible. People with diabetes consistently report that CGM changes their dietary choices in ways that HbA1c testing — available only 4 times per year — never could.
CGM for Type 1 diabetes
For Type 1 diabetes, CGM is increasingly considered standard of care. The combination of real-time glucose data and automated insulin delivery (closed-loop AID systems) has produced the most significant advancement in Type 1 management in decades.
Closed-loop AID systems — where a CGM communicates directly with an insulin pump to automatically adjust insulin delivery — require a compatible CGM. The Dexcom G7 has the broadest AID compatibility, working with Tandem t:slim X2 (Control-IQ), Omnipod 5, and other systems.
Best devices for Type 1: Dexcom G7 for closed-loop AID and maximum integrations; FreeStyle Libre 3 for best accuracy and cost if not using a closed-loop system.
Insurance coverage: CGM is covered by Medicare and most private insurance for all people with Type 1 diabetes. Prior authorization may be required — your endocrinologist's office can assist.
CGM for Type 2 diabetes
CGM use in Type 2 diabetes has expanded significantly. The clinical case is strongest for insulin users, but people managing Type 2 without insulin also benefit from real-time glucose feedback.
On insulin: CGM reduces hypoglycemia, improves time in range, and enables tighter glucose control. Covered by most insurance for insulin-using Type 2 patients. The FreeStyle Libre 3 is the top recommendation for most Type 2 insulin users — best accuracy, 14-day wear, and lower cost than Dexcom.
Not on insulin: CGM provides behavioral feedback that motivates dietary change. Coverage is more variable — check with your insurer. If insurance doesn't cover it, OTC options (Stelo, Lingo) are available without a prescription for $89–99/month.
Best CGM devices for diabetes 2026
Dexcom G7 — best for closed-loop AID, Apple Watch, and maximum integrations. Rating: 9.1/10. Full review →
FreeStyle Libre 3 — best accuracy (7.9% MARD), 14-day wear, lower cost. Best value for most diabetes patients not using closed-loop AID. Rating: 8.8/10. Full review →
Medtronic Guardian 4 — best for Medtronic insulin pump users wanting closed-loop control. Limited value outside the Medtronic ecosystem.
All three devices above require a prescription. OTC CGMs (Stelo, Lingo) are not appropriate for insulin-using diabetes management — they lack the clinical alerts and insulin-dosing clearance needed for safe diabetes care.
How to get started with CGM
Step 1: Talk to your endocrinologist or diabetes care provider. Ask specifically about CGM and which device is best for your management approach (AID system compatibility, insulin regimen, etc.).
Step 2: Get a prescription. Your prescriber will write a CGM prescription and may also handle prior authorization with your insurer.
Step 3: Verify insurance coverage. Contact your insurer and confirm which devices are covered on your plan's formulary and what your cost-sharing will be.
Step 4: Order through a durable medical equipment (DME) supplier, your pharmacy, or directly from the manufacturer. Setup takes about 30–60 minutes for the first sensor.
Frequently asked questions
Sources & Further Reading
This article draws on the following clinical sources:
- American Diabetes Association. Standards of Medical Care in Diabetes 2026. diabetesjournals.org/care →
- CDC. National Diabetes Statistics Report. cdc.gov/diabetes →
- Continuous Glucose Monitoring Consensus Conference Report. Diabetes Care. PubMed →
- Dexcom G7 System User Guide — FDA 510(k) Clearance K221645. FDA Device Database →